Ikena Oncology Inc. (IKNA)
NASDAQ: IKNA
· Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM
Ikena Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 58.29M | 36.76M | 39.39M | 45.19M | 44.27M | 52.85M | 119.89M | 121.28M | 70.87M | 29.33M | 59.92M | 67.07M | 48.49M | 46.88M | 232.22M | 245.9M | 264M | 281.01M |
Short-Term Investments | 37.35M | 77.29M | 84.99M | 92.84M | 101.15M | 104.5M | 55.57M | 75.66M | 86.44M | 108.48M | 97.03M | 107.29M | 144.32M | 165.5M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.28M | 1.28M | 1.28M | 1.28M | 3.67M | n/a | 872K | 3.79M | 3.18M | 3.18M | 2.39M | 872K | 872K | 872K |
Other Long-Term Assets | 24.17M | 10.23M | 10.11M | 2.61M | 1.33M | 4.23M | 4.13M | 2.8M | n/a | 3.18M | 2.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.37M | 2.95M | 2.78M | 3.5M | 3.9M | 3.82M | 1.15M | 1.02M | 731K | 1.41M | 964K | 1.18M | 2.3M | 1.05M | 629K | 1.03M | 2.98M | 634K |
Total Current Assets | 99.01M | 117M | 127.17M | 141.53M | 149.32M | 161.17M | 178.66M | 200.63M | 160.65M | 141.18M | 160.01M | 177.98M | 199.15M | 216.05M | 236.52M | 251.87M | 268.71M | 283.23M |
Property-Plant & Equipment | 2.98M | 3.61M | 4.23M | 4.84M | 5.55M | 6.11M | 8.02M | 10.63M | 7.45M | 8.04M | 8.46M | 8.7M | 8.86M | 8.52M | 8.98M | 8.97M | 9.24M | 9.56M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 27.15M | 13.84M | 14.34M | 7.46M | 8.16M | 11.62M | 13.43M | 14.7M | 11.12M | 11.22M | 12.25M | 12.49M | 12.04M | 11.7M | 11.36M | 9.84M | 10.12M | 10.43M |
Total Assets | 126.17M | 130.84M | 141.51M | 148.99M | 157.49M | 172.78M | 192.09M | 215.34M | 171.76M | 152.4M | 172.26M | 190.47M | 211.18M | 227.75M | 247.88M | 261.7M | 278.83M | 293.66M |
Account Payables | 512K | 805K | 897K | 1.54M | 1.41M | 1.91M | 2.07M | 3.95M | 1.77M | 2.76M | 2.09M | 2.36M | 4.09M | 2.39M | 2.38M | 1.93M | 2.47M | 2.53M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 659K | 1.84M | 3.85M | 9.16M | 12.11M | 17.19M | 16.75M | 17.1M | 22.57M | 22.47M | 22.34M |
Short-Term Debt | n/a | n/a | n/a | n/a | 3.69M | n/a | 3.56M | 3.47M | 1.94M | n/a | 1.91M | 1.89M | 1.88M | 1.86M | 1.85M | 1.84M | 1.83M | 1.58M |
Other Current Liabilities | 522K | 447K | 1.75M | 3.78M | -2M | 3.23M | 1.71M | 4.76M | 2.59M | 1.14M | 3.2M | 4.05M | 1.61M | 1.54M | 1.19M | 454K | 667K | 1.17M |
Total Current Liabilities | 7.32M | 8.79M | 10.78M | 9.24M | 8.2M | 10.17M | 14.21M | 19.27M | 12.01M | 13.95M | 21.5M | 25.04M | 28.51M | 25.33M | 27.19M | 30.57M | 30.54M | 30.02M |
Long-Term Debt | n/a | 2.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.09M | 1.08M | 1.06M | 1.04M | 1.03M | 964K | 950K | 32.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 2.94M | 3.79M | 4.8M | 5.52M | 6.43M | 7.27M | 8.13M | 40.72M | 3.06M | 3.43M | 3.79M | 6.64M | 8.3M | 9.46M | 12.81M | 27.87M | 32.02M | 36M |
Total Liabilities | 10.26M | 12.59M | 15.58M | 14.76M | 14.63M | 17.43M | 22.34M | 59.99M | 15.06M | 17.38M | 25.29M | 31.68M | 36.82M | 34.79M | 40M | 58.44M | 62.57M | 66.02M |
Total Debt | 5.68M | 6.61M | 7.52M | 8.39M | 9.09M | 9.74M | 10.74M | 11.49M | 4.99M | 5.35M | 5.69M | 6.03M | 6.36M | 6.68M | 6.99M | 7.29M | 7.58M | 7.64M |
Common Stock | 48K | 48K | 48K | 48K | 48K | 48K | 48K | 44K | 42K | 36K | 36K | 36K | 36K | 36K | 36K | 36K | 36K | 36K |
Retained Earnings | -343M | -340.24M | -331.62M | -322.5M | -312.26M | -298.53M | -282.38M | -262.9M | -245.55M | -228.44M | -214.22M | -200.12M | -182.78M | -162.29M | -145.45M | -148.25M | -133.74M | -121.06M |
Comprehensive Income | 65K | 99K | 68K | 240K | -350K | -313K | -48K | -290K | -456K | -491K | -763K | -1.18M | -1.1M | -478K | n/a | -261.7M | -278.83M | -293.66M |
Shareholders Equity | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M | 169.76M | 155.34M | 156.7M | 135.02M | 146.97M | 158.79M | 174.37M | 192.96M | 207.88M | 203.26M | 216.26M | 227.64M |
Total Investments | 37.35M | 77.29M | 84.99M | 92.84M | 102.43M | 105.78M | 56.85M | 75.66M | 86.44M | 108.48M | 97.03M | 107.29M | 144.32M | 165.5M | 2.39M | 872K | 872K | 872K |